During the past decade, Nova Scotia Cancer Centre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 14 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nova Scotia Cancer Centre" #1 sponsor was "Radiation Therapy Oncology Group" with 39 trials, followed by "NCIC Clinical Trials Group" with 20 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "Ontario Clinical Oncology Group (OCOG)" with 5 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nova Scotia Cancer Centre" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "NCIC Clinical Trials Group" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator and "Eastern Cooperative Oncology Group" with 6 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Nova Scotia Cancer Centre" are "Prostate Cancer" (14 trials), "Lung Cancer" (12 trials), "Head and Neck Cancer" (9 trials), "Breast Cancer" (7 trials) and "Metastatic Cancer" (7 trials). Many other conditions were trialed in "Nova Scotia Cancer Centre" in a lesser frequency.

Most popular intervention types in "Nova Scotia Cancer Centre" are "Drug" (77 trials), "Radiation" (46 trials), "Procedure" (25 trials), "Biological" (15 trials) and "Other" (11 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (34 trials), "cisplatin" (11 trials), "conventional surgery" (10 trials), "filgrastim" (8 trials) and "paclitaxel" (8 trials). Other intervention names were less common.

The vast majority of trials in "Nova Scotia Cancer Centre" are 73 trials for "All" genders, 14 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Nova Scotia Cancer Centre". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 88 completed trials in Nova Scotia Cancer Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nova Scotia Cancer Centre, 8 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".